Business Description
Telomir Pharmaceuticals is a Miami-based biotech company working to develop treatments that target the root causes of aging and the diseases that come with it. Its main focus is Telomir-1, an oral drug intended to treat a wide range of conditions, including Alzheimer's disease, Type 2 diabetes, certain cancers, and rare genetic disorders. Founded in 2021 and previously operating under the name Metallo Therapies, the company is still in the early stages of research and development.
